2025
President’s Innovation Challenge
-
Limax Biosciences
Treating internal and external injuries with a stretchable adhesive hydrogel.
![]()
-
Modulate Bio
Developing therapies to treat neurological disorders, including Essential Tremor, epilepsy, and anxiety.
![Modulate team lead]()
-
Nucyrna Therapeutics
Redefining RNA-targeting therapeutics, starting in neurodegenerative diseases.
![Nucyrna team lead]()
-
Regatta BIO
Developing cellular therapies to restore immune tolerance and prevent immune system-related diseases.
And the Winner Is...
On May 7, 25 finalists will pitch live for a share of $517,000 in Bertarelli Foundation funding.
